17 August 2022
Latham & Watkins Advises Boston Scientific Corporation in its Acquisition of Obsidio, Inc.
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Julie Scallen Lead | Latham & Watkins LLP | Partner | corporate | Boston |
| Stefanie Vincent | Latham & Watkins LLP | Associate | corporate | Boston |
| Michael Casagrande | Latham & Watkins LLP | Associate | corporate | Boston |
| Andrew Rondeau | Latham & Watkins LLP | Associate | corporate | Boston |
| Nicole Angelica | Latham & Watkins LLP | Associate | corporate | Boston |
| Nicholas DeNovio | Latham & Watkins LLP | Partner | tax | Washington, D.C. |
| Pierce Pandolph | Latham & Watkins LLP | Associate | tax | Washington, D.C. |
| Emmanuel Kassim | Latham & Watkins LLP | Associate | tax | Washington, D.C. |
| Benjamin Rosemergy | Latham & Watkins LLP | Partner | benefits and employment | Chicago |
| Daniel Gocek | Latham & Watkins LLP | Associate | benefits and employment | Chicago |
| Elizabeth Richards | Latham & Watkins LLP | Partner | healthcare regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Counsel | healthcare regulatory | Bay Area |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Boston Scientific CorporationBuy-side
- Counterparties
- Obsidio, Inc. (Sell-side)